Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,592.00
-40.60 (-2.49%)
Apr 21, 2026, 3:30 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 309.52 billion as of April 21, 2026. Its market cap has increased by 59.28% in one year.
Market Cap
309.52B
Enterprise Value
322.41B
Revenue
88.50B
Ranking
n/a
PE Ratio
35.57
Stock Price
1,592.00
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 309.52B, an increase of 20.46%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 309.52B | 19.66% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 667.41B |
| Glenmark Pharmaceuticals | 634.81B |
| Laurus Labs | 613.14B |
| Ipca Laboratories | 372.51B |
| Ajanta Pharma | 348.46B |
| Gland Pharma | 296.13B |
| Wockhardt | 226.73B |
| NATCO Pharma | 200.55B |